Published in Gene on August 30, 1991
The physical map of the chromosome of a serogroup A strain of Neisseria meningitidis shows complex rearrangements relative to the chromosomes of the two mapped strains of the closely related species N. gonorrhoeae. J Bacteriol (1995) 3.10
Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system. Clin Diagn Lab Immunol (1998) 1.72
Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin Diagn Lab Immunol (1998) 1.71
Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine. Infect Immun (1996) 1.54
Molecular analysis of the serotyping antigens of Neisseria meningitidis. Infect Immun (1992) 1.51
Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis. Infect Immun (1993) 1.21
Identification of meningococcal serosubtypes by polymerase chain reaction. J Clin Microbiol (1992) 1.19
Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med (1996) 1.15
Analysis of Neisseria meningitidis class 3 outer membrane protein gene variable regions and type identification using genetic techniques. Infect Immun (1995) 1.13
Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their oxidative burst. Infect Immun (1995) 1.01
Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity. Future Microbiol (2010) 0.92
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1992) 0.75
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Handling of scientific dishonesty in the Nordic countries. National Committees on Scientific Dishonesty in the Nordic Countries. Lancet (1999) 2.66
Effect of polymyxin on the ultrastructure of the outer membrane of wild-type and polymyxin-resistant strain of Salmonella. J Bacteriol (1976) 2.43
Nucleotide sequence of the promoter and NH2-terminal signal peptide region of the alpha-amylase gene from Bacillus amyloliquefaciens. Gene (1981) 2.30
Transcription and translation of foreign genes in Bacillus subtilis by the aid of a secretion vector. J Bacteriol (1985) 2.08
Bacteriophage-resistant mutants of Salmonella typhimurium deficient in two major outer membrane proteins. J Bacteriol (1976) 2.02
Decreased binding of polymyxin by polymyxin-resistant mutants of Salmonella typhimurium. J Bacteriol (1979) 1.82
Formation of protein micelles from amphiphilic membrane proteins. Proc Natl Acad Sci U S A (1978) 1.80
Secretion of Escherichia coli beta-lactamase from Bacillus subtilis by the aid of alpha-amylase signal sequence. Proc Natl Acad Sci U S A (1982) 1.74
Bacillus licheniformis penicillinase synthesized in Escherichia coli contains covalently linked fatty acid and glyceride. Proc Natl Acad Sci U S A (1981) 1.71
The PrsA lipoprotein is essential for protein secretion in Bacillus subtilis and sets a limit for high-level secretion. Mol Microbiol (1993) 1.65
Membrane-bound and secreted forms of penicillinase from Bacillus licheniformis. J Mol Biol (1978) 1.62
A novel two-component regulatory system in Bacillus subtilis for the survival of severe secretion stress. Mol Microbiol (2001) 1.50
The role of lipoprotein processing by signal peptidase II in the Gram-positive eubacterium bacillus subtilis. Signal peptidase II is required for the efficient secretion of alpha-amylase, a non-lipoprotein. J Biol Chem (1999) 1.45
D-Alanine substitution of teichoic acids as a modulator of protein folding and stability at the cytoplasmic membrane/cell wall interface of Bacillus subtilis. J Biol Chem (2000) 1.44
Mutant of Escherichia coli K-12 defective in D-glucosamine biosynthesis. J Bacteriol (1971) 1.40
Bacteriophage attachment to the somatic antigen of salmonella: effect of o-specific structures in leaky R mutants and s, t1 hybrids. Infect Immun (1970) 1.28
A gene (prsA) of Bacillus subtilis involved in a novel, late stage of protein export. Mol Microbiol (1991) 1.26
A precursor form of the penicillinase from Bacillus licheniformis. FEBS Lett (1978) 1.24
Bacillus subtilis PrsA is required in vivo as an extracytoplasmic chaperone for secretion of active enzymes synthesized either with or without pro-sequences. Mol Microbiol (1993) 1.22
Asymmetric and symmetric membrane reconstitution by detergent elimination. Studies with Semliki-Forest-virus spike glycoprotein and penicillinase from the membrane of Bacillus licheniformis. Eur J Biochem (1981) 1.21
Lipid modification of prelipoproteins is dispensable for growth but essential for efficient protein secretion in Bacillus subtilis: characterization of the Lgt gene. Mol Microbiol (1999) 1.16
Quantitation of the capacity of the secretion apparatus and requirement for PrsA in growth and secretion of alpha-amylase in Bacillus subtilis. J Bacteriol (2001) 1.16
Mutants of Bacillus subtilis defective in protein export. J Gen Microbiol (1988) 1.13
Molecular analysis of an operon in Bacillus subtilis encoding a novel ABC transporter with a role in exoprotein production, sporulation and competence. Microbiology (1996) 1.12
Protein secretion in bacilli. Curr Top Microbiol Immunol (1986) 1.11
Teichoic acid antibody test: its use in patients with coagulase-positive staphylococcal bacteremia. Arch Intern Med (1977) 1.09
Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun (1998) 1.09
Production of pneumolysin, a pneumococcal toxin, in Bacillus subtilis. Gene (1989) 1.06
A strong antibody response to the periplasmic C-terminal domain of the OmpA protein of Escherichia coli is produced by immunization with purified OmpA or with whole E. coli or Salmonella typhimurium bacteria. Infect Immun (1990) 1.05
Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology (1999) 1.03
Expression and secretion of pertussis toxin subunit S1 in Bacillus subtilis. Microb Pathog (1987) 1.02
Biosynthesis of T1 antigen in Salmonella: origin of D-galactofuranose and D-ribofuranose residues. J Bacteriol (1971) 1.00
The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity. Mol Microbiol (1992) 0.98
Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals. Microb Pathog (1989) 0.97
Ecs, an ABC transporter of Bacillus subtilis: dual signal transduction functions affecting expression of secreted proteins as well as their secretion. Mol Microbiol (1999) 0.96
Immunochemical studies on T1,S hybrids of Salmonella paratyphi--B. Ann Med Exp Biol Fenn (1967) 0.96
Analysis of polyamines as their dabsyl derivatives by reversed-phase high-performance liquid chromatography. Anal Biochem (1987) 0.96
Biological activities of lipoteichoic acid and peptidoglycan-teichoic acid of Bacillus subtilis 168 (Marburg). J Gen Microbiol (1993) 0.96
Biosynthesis of T1 antigen in Salmonella: biosynthesis in a cell-free system. J Bacteriol (1971) 0.96
Secretion of heterologous proteins in Bacillus subtilis can be improved by engineering cell components affecting post-translocational protein folding and degradation. J Appl Microbiol (2005) 0.95
Inheritance of Salmonella T1 antigen. Ann Med Exp Biol Fenn (1967) 0.95
Immunological properties of recombinant porin of Haemophilus influenzae type b expressed in Bacillus subtilis. Infect Immun (1993) 0.94
The bacterial factors which stimulate neutrophils may be derived from procaryote signal peptides. FEBS Lett (1980) 0.94
Chlamydial antibodies in patients with previous acute anterior uveitis. Invest Ophthalmol Vis Sci (2001) 0.93
Secretion of the Escherichia coli outer membrane proteins OmpA and OmpF in Bacillus subtilis is blocked at an early intracellular step. Mol Microbiol (1992) 0.93
Immunochemical characterization of major outer membrane components from Salmonella typhimurium. Infect Immun (1981) 0.93
Mitogenic effect by lipopolysaccharide and pokeweed lectin on density-inhibited chick embryo fibroblasts. J Exp Med (1973) 0.92
The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis. Vaccine (1995) 0.91
The production, by recombination, of Salmonella forms with both T-1 and O specifities. Acta Pathol Microbiol Scand (1965) 0.90
The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes. Microb Pathog (1995) 0.90
Expansion of a novel pulmonary CD3(-) CD4(+) CD8(+) cell population in mice during Chlamydia pneumoniae infection. Infect Immun (1998) 0.88
Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model. Microb Pathog (1990) 0.88
Synthesis of OmpA protein of Escherichia coli K12 in Bacillus subtilis. J Gen Microbiol (1986) 0.87
Proteome and transcriptome based analysis of Bacillus subtilis cells overproducing an insoluble heterologous protein. Appl Microbiol Biotechnol (2001) 0.86
Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2). Vaccine (2000) 0.85
Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte- derived macrophages. Arterioscler Thromb Vasc Biol (2001) 0.84
The effect of T1 antigen on the virulence of salmonella strains for mice. J Gen Microbiol (1971) 0.84
Expression of pertussis toxin subunit S4 as an intracytoplasmic protein in Bacillus subtilis. Vaccine (1990) 0.83
Secretion of Semliki Forest virus membrane glycoprotein E1 from Bacillus subtilis. Virus Res (1985) 0.83
Production and secretion of pertussis toxin subunits in Bacillus subtilis. FEMS Microbiol Lett (1990) 0.83
Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100. Vaccine (1996) 0.82
Immunogenicity and protective efficacy of pertussis toxin subunit S1 produced by Bacillus subtilis. Microb Pathog (1991) 0.82
Picornavirus proteins share antigenic determinants with heat shock proteins 60/65. J Med Virol (2000) 0.80
Antibody production to a meningococcal outer membrane protein cloned into liv Salmonella typhimurium aroA vaccine strain. Microb Pathog (1989) 0.80
T2 lipopolysaccharide antigen of Salmonella: genetic determination of T2 and properties of the T2, T2,S, and T2,SR Forms. Infect Immun (1976) 0.80
Enhanced secretion of heterologous cyclodextrin glycosyltransferase by a mutant of Bacillus licheniformis defective in the D-alanylation of teichoic acids. Lett Appl Microbiol (2003) 0.79
Assessment of non-protein impurities in potential vaccine proteins produced by Bacillus subtilis. Vaccine (1993) 0.79
High level production of Escherichia coli outer membrane proteins OmpA and OmpF intracellularly in Bacillus subtilis. FEMS Microbiol Lett (1991) 0.79
Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model. Vaccine (2006) 0.79
Heterologous production of the P1 porin of Neisseria meningitidis in bacillus subtilis: the effect of an N-terminal extension on the presentation of native-like epitopes. Microb Pathog (1995) 0.77
Cloning of an outer membrane protein of Neisseria meningitidis in Escherichia coli. Microb Pathog (1987) 0.77
Incompatibility of outer membrane proteins OmpA and OmpF of Escherichia coli with secretion in Bacillus subtilis: fusions with secretable peptides. FEMS Microbiol Lett (1992) 0.76
T2 lipopolysaccharide antigen of Salmonella: comparison of the properties of T2 and mucoid forms. Infect Immun (1976) 0.76
Ultrastructure of the envelope during glucosamine starvation and penicillin treatment of a mutant of Escherichia coli. J Gen Microbiol (1974) 0.76
Amino-terminal heterogeneity of E. coli TEM-beta-lactamase secreted from Bacillus subtilis. FEBS Lett (1986) 0.75
Conformation of Escherichia coli outer membrane protein OmpA produced in Bacillus subtilis: influence of lipopolysaccharide. FEMS Microbiol Lett (1993) 0.75
[Traveller's diarrhea]. Duodecim (1977) 0.75
[Production of foreign proteins by microbes]. Duodecim (1983) 0.75
Safe biotechnology 9: values in risk assessment for the environmental application of microorganisms. The Safety in Biotechnology Working Party of the European Federation of Biotechnology. Trends Biotechnol (1999) 0.75
Influence of O- and T1 side-chains on the attachment of bacteriophages to the somatic antigen of Salmonella. J Gen Microbiol (1969) 0.75
[Contagious antibiotic-resistant infections]. Duodecim (1968) 0.75
[Scientific fraud and misconduct--need for comprehensive terminology]. Nord Med (1998) 0.75
Protective activities of "Bordetella pertussis" Tn5 mutants in mice. Ann Sclavo Collana Monogr (1986) 0.75
Secretion of Escherichia coli beta-lactamase from Bacillus subtilis by the aid of alpha-amylase signal sequence. 1982. Biotechnology (1992) 0.75
Bacillus subtilis alpha-amylase: the rate limiting step of secretion is growth phase-independent. FEMS Microbiol Lett (1999) 0.75
Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice. Scand J Immunol (2005) 0.75
The 20 kDa C-terminally truncated form of pertussis toxin subunit S1 secreted from Bacillus subtilis. FEMS Microbiol Lett (1991) 0.75